Clearmind Medicine To Fund Second R&D Partnership With Hebrew University’s Technology Transfer Company
Ryan Allway September 27th, 2021 Psychedelics Toronto, Ontario–(Newsfile Corp. – September 27, 2021) – Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, is pleased to announce... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )